Projected Income Statement: Merck KGaA

Forecast Balance Sheet: Merck KGaA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 8,902 8,328 7,959 7,784 - 7,042 4,255 2,403
Change - -6.45% -4.43% -2.2% - - -39.58% -43.53%
Announcement Date 3/3/22 3/2/23 3/7/24 3/6/25 3/5/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Merck KGaA

Fiscal Period: December 2021 2022 2023 2024 2026 2027 2028
CAPEX 1 1,066 1,531 2,024 2,183 1,713 1,890 1,808
Change - 43.73% 32.14% 7.88% - 10.37% -4.35%
Free Cash Flow (FCF) 1 3,550 2,728 1,915 2,884 3,120 2,930 3,156
Change - -23.17% -29.8% 50.64% - -6.09% 7.7%
Announcement Date 3/3/22 3/2/23 3/7/24 3/6/25 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Merck KGaA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 31% 30.81% 28% 28.7% 28.95% 27.86% 28.95% 29.47%
EBIT Margin (%) 21.23% 20.12% 17.19% 17.23% 17.06% 18.12% 19.51% 20.3%
EBT Margin (%) 19.93% 19.28% 16.6% 16.72% 15.68% 15.96% 18.18% 19.08%
Net margin (%) 15.52% 14.96% 13.45% 13.12% 12.36% 12.82% 14.34% 14.73%
FCF margin (%) 18.03% 12.27% 9.12% 13.63% - 14.83% 13.29% 13.67%
FCF / Net Income (%) 116.22% 82.02% 67.8% 103.89% - 115.67% 92.66% 92.83%

Profitability

        
ROA 8.7% 9.31% 7.61% 5.47% - 5.45% 5.9% 6.24%
ROE 19.81% 18.5% 14.03% 13.26% - 11.46% 11.3% 11.7%

Financial Health

        
Leverage (Debt/EBITDA) 1.46x 1.22x 1.35x 1.28x - 1.2x 0.67x 0.35x
Debt / Free cash flow 2.51x 3.05x 4.16x 2.7x - 2.26x 1.45x 0.76x

Capital Intensity

        
CAPEX / Current Assets (%) 5.41% 6.89% 9.64% 10.32% - 8.14% 8.57% 7.83%
CAPEX / EBITDA (%) 17.46% 22.36% 34.42% 35.96% - 29.23% 29.6% 26.58%
CAPEX / FCF (%) 30.01% 56.14% 105.68% 75.68% - 54.88% 64.51% 57.29%

Items per share

        
Cash flow per share 1 10.62 9.796 8.703 10.55 - 11.23 11.35 11.78
Change - -7.73% -11.15% 21.19% - - 1.03% 3.77%
Dividend per Share 1 1.85 2.2 2.2 2.2 - 2.403 2.516 2.539
Change - 18.92% 0% 0% - - 4.73% 0.93%
Book Value Per Share 1 49.08 59.63 61.36 68.79 - 73.75 80.26 84.02
Change - 21.5% 2.9% 12.11% - - 8.83% 4.68%
EPS 1 7.03 7.65 6.49 6.39 6 6.277 7.382 7.951
Change - 8.82% -15.16% -1.54% -6.1% 4.61% 17.62% 7.71%
Nbr of stocks (in thousands) 434,778 434,778 434,778 434,778 434,778 434,778 434,778 434,778
Announcement Date 3/3/22 3/2/23 3/7/24 3/6/25 3/5/26 - - -
1EUR
Estimates
2026 *2027 *
P/E ratio 17.2x 14.6x
PBR 1.46x 1.34x
EV / Sales 2.56x 2.32x
Yield 2.23% 2.33%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
107.80EUR
Average target price
147.12EUR
Spread / Average Target
+36.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Financials Merck KGaA
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW